Severe Thrombocytopenia (<50×109 Cells/l) Associated with Glycoprotein IIb/IIIa Inhibitors in Patients with Cardio Vascular Illness: A Cohort Study On Clinical Course and Outcomes

Abstract 4452 Glycoprotein IIb/IIIa inhibitors (GPI) improve outcomes in patients following percutaneous coronary intervention (PCI) and troponin positive acute coronary syndrome. However, GPI's can result in severe but transient thrombocytopenia (platelet count

Saved in:
Bibliographic Details
Published in:Blood 2009-11, Vol.114 (22), p.4452-4452
Main Authors: Viswanathan, Girish N, Mayurathan, Gnanamoorthy, Hardy, John, Jamieson, Sheila, Kestevan, Patrick, Zaman, Azfar
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract 4452 Glycoprotein IIb/IIIa inhibitors (GPI) improve outcomes in patients following percutaneous coronary intervention (PCI) and troponin positive acute coronary syndrome. However, GPI's can result in severe but transient thrombocytopenia (platelet count
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V114.22.4452.4452